![American Society of Clinical Oncology American Society of Clinical Oncology](https://54d4f314-8f94-415c-acb7-fd0a6332f070.s3.amazonaws.com/403/403__asco-logo-lg__274272709.png?X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAU2BE4PNFKE2WZV7V%2F20240727%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20240727T012849Z&X-Amz-SignedHeaders=host&X-Amz-Expires=86400&X-Amz-Signature=19ffee7f5cdedf61ec63562e3cffee8fdec9600735cad8840d6642907b46ebfb)
Treatment of Locally Advanced Esophageal Carcinoma
Publication Date: July 28, 2021
Key Points
Key Points
- Esophageal cancer is the 6th most common cancer worldwide, with an estimated 450,000 deaths per year.
- Multimodality therapy for patients with locally advanced esophageal carcinoma is recommended.
- For the subgroup of patients with adenocarcinoma, preoperative chemoradiotherapy or perioperative chemotherapy should be offered.
- For the subgroup of patients with squamous cell carcinoma, preoperative chemoradiotherapy or chemoradiotherapy without surgery should be offered.
Treatment
...reatme...
...erapy should be offered to patients wit...
...ve chemoradiotherapy (CRT) or perioperat...
...e CRT or CRT without surgery (definitive...
...ce StatementFor patients with esophag...
...commendation Update – August 2021...
...llowing neoadjuvant CRT and surgery, nivo...